Expeditious Vaccine Advice with Legitimate, Unbiased, Apolitical, and Technical Expertise Act or the EVALUATE Act This bill requires the Food and Drug Administration, before licensing or authorizing any COVID-19 (i.e., coronavirus disease 2019) vaccine, to receive advisory committee recommendations concerning the vaccine's safety and effectiveness.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Introduced in House
Referred to the House Committee on Energy and Commerce.
Health
Advisory bodiesCardiovascular and respiratory healthDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careFood and Drug Administration (FDA)Government information and archivesImmunology and vaccinationInfectious and parasitic diseasesLicensing and registrationsMedical researchPublic participation and lobbying
EVALUATE Act
USA116th CongressHR-7971| House
| Updated: 8/7/2020
Expeditious Vaccine Advice with Legitimate, Unbiased, Apolitical, and Technical Expertise Act or the EVALUATE Act This bill requires the Food and Drug Administration, before licensing or authorizing any COVID-19 (i.e., coronavirus disease 2019) vaccine, to receive advisory committee recommendations concerning the vaccine's safety and effectiveness.
Advisory bodiesCardiovascular and respiratory healthDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationEmergency medical services and trauma careFood and Drug Administration (FDA)Government information and archivesImmunology and vaccinationInfectious and parasitic diseasesLicensing and registrationsMedical researchPublic participation and lobbying